Posts by CT Team

F-Star collaboration

As announced today (May 31), Confluence Tax is delighted to have assisted F-star on the acquisition of the asset-centric vehicle F-Star Gamma by Denali Therapeutics, leveraging F-star’s Modular Antibody Technology™ beyond immuno-oncology. Read the full press release here. 

Read More

BREXIT AND TAX: WHAT’S IN STORE FOR BIOTECHS?

Union-Jack-flag-with-Brexit-word

THERE IS no doubt that biotech fundraising rounds are getting bigger, companies are getting bigger and, as tax advisors, we are being faced with previously unheard of issues. Take profits – these could result in corporation tax liabilities, groups so large or profitable that they cannot claim SME R&D tax credits or future milestone income…

Read More

Finalist in Tolley’s Taxation Awards 2018 – Confluence Tax

Tolleys-Taxation-Awards-2018-Finalist-logo

  CONFLUENCE Tax is delighted to announce the team has been shortlisted in the Tolley’s Taxation Awards 2018. The team is a finalist in the category Best Independent Consultancy Firm and is the smallest company to be selected. ‘It’s fantastic to be chosen as a finalist, especially as it’s the first time we’ve applied for an award.…

Read More

Should your company elect in to the Patent Box?

Light bulbs hanging from a ceiling

You’re not out of time but don’t be out of touch… Bad Hall & Oates songs aside, the Patent Box is a complicated beast and 2018 is likely to be a crucial year for determining whether you should elect in. So here is some clarity if yours is a loss-making company. The Patent Box provides…

Read More

UK: A GREAT OPTION FOR US R&D

Triangular sign saying explore on a wooden background

WHY THE UK ROCKS FOR RESEARCH During a January visit to San Francisco to coincide with the JP Morgan conference, it was encouraging to hear from one US biotech company CFO how he considered the UK an attractive place to base his company’s research activities – above and beyond any other. Among the reasons why…

Read More